Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00011
|
|||||
Drug Name |
2-Deoxyglucose
|
|||||
Synonyms |
2-DG; 2-DG (epilepsy), NeurogenomeX; 2-DG (epilepsy), NeurogenomeX); 2-deoxy-D-glucose; D-arabinohexose; Dextrose; Glucose; University of Wisconsin-Madison/NeuroGenomeX
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Cancer [ICD11: 2A00-2F9Z] | Phase 1/2 | [1] | |||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C6H12O5
|
|||||
Canonical SMILES |
C(C=O)C(C(C(CO)O)O)O
|
|||||
InChI |
InChI=1S/C6H12O5/c7-2-1-4(9)6(11)5(10)3-8/h2,4-6,8-11H,1,3H2/t4-,5-,6+/m1/s1
|
|||||
InChIKey |
VRYALKFFQXWPIH-PBXRRBTRSA-N
|
|||||
CAS Number |
CAS 61-58-5
|
|||||
Pharmaceutical Properties | Molecular Weight | 164.16 | Topological Polar Surface Area | 98 | ||
Heavy Atom Count | 11 | Rotatable Bond Count | 5 | |||
Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 5 | |||
XLogP |
-2.9
|
|||||
PubChem CID | ||||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | GLUT1 | Transporter Info | Glucose transporter type 1 | Substrate | [2] | |
GLUT10 | Transporter Info | Glucose transporter type 10 | Substrate | [3] | ||
GLUT12 | Transporter Info | Glucose transporter type 12 | Substrate | [4] | ||
GLUT14 | Transporter Info | Glucose transporter type 14 | Substrate | [5] | ||
GLUT2 | Transporter Info | Glucose transporter type 2 | Substrate | [6] | ||
GLUT3 | Transporter Info | Glucose transporter type 3 | Substrate | [7] | ||
GLUT4 | Transporter Info | Glucose transporter type 4 | Substrate | [8] | ||
GLUT6 | Transporter Info | Glucose transporter type 6 | Substrate | [9] | ||
GLUT7 | Transporter Info | Glucose transporter type 7 | Substrate | [9] | ||
GLUT8 | Transporter Info | Glucose transporter type 8 | Substrate | [9] | ||
SGLT1 | Transporter Info | Sodium/glucose cotransporter 1 | Substrate | [10] | ||
SGLT3 | Transporter Info | Sodium/glucose cotransporter 3 | Substrate | [11] | ||
SGLT4 | Transporter Info | Sodium/glucose cotransporter 4 | Substrate | [12] | ||
SGLT5 | Transporter Info | Sodium/glucose cotransporter 5 | Substrate | [11] | ||
SLC45A1 | Transporter Info | Proton-associated sugar transporter A | Substrate | [13] | ||
Drug-Transporter Activity Data | ||||||
Drug-Transporter Activity Data | GLUT10 | Transporter Info | Km = 300 microM | Xenopus oocytes-GLUT10 | [3] | |
GLUT2 | Transporter Info | Km = 1120 microM | Human pancreatic beta cells-GLUT2 | [6] | ||
GLUT7 | Transporter Info | Km = 300 microM | Xenopus oocytes-GLUT7 | [9] | ||
GLUT8 | Transporter Info | Km = 2000 microM | Xenopus oocytes-GLUT8 | [9] | ||
References | ||||||
1 | ClinicalTrials.gov (NCT00633087) A Phase I/II Trial of 2-Deoxyglucose (2DG) for the Treatment of Advanced Cancer and Hormone Refractory Prostate Cancer | |||||
2 | Glutamine 161 of Glut1 glucose transporter is critical for transport activity and exofacial ligand binding. J Biol Chem. 1994 Aug 12;269(32):20533-8. | |||||
3 | Sequence and functional analysis of GLUT10: a glucose transporter in the Type 2 diabetes-linked region of chromosome 20q12-13.1. Mol Genet Metab. 2001 Sep-Oct;74(1-2):186-99. | |||||
4 | The human facilitative glucose transporter GLUT12: Expression and regulation in Caco-2 and 3T3-L1cells. | |||||
5 | The SLC2A14 gene, encoding the novel glucose/dehydroascorbate transporter GLUT14, is associated with inflammatory bowel disease. Am J Clin Nutr. 2017 Dec;106(6):1508-1513. | |||||
6 | GLUT2 (SLC2A2) is not the principal glucose transporter in human pancreatic beta cells: implications for understanding genetic association signals at this locus. Mol Genet Metab. 2011 Dec;104(4):648-53. | |||||
7 | Ascorbic acid-dependent GLUT3 inhibition is a critical step for switching neuronal metabolism. J Cell Physiol. 2011 Dec;226(12):3286-94. | |||||
8 | Need for GLUT4 activation to reach maximum effect of insulin-mediated glucose uptake in brown adipocytes isolated from GLUT4myc-expressing mice. Diabetes. 2002 Sep;51(9):2719-26. | |||||
9 | Functional Properties and Genomics of Glucose Transporters. Curr Genomics. 2007 Apr; 8(2): 113128. | |||||
10 | The role of SGLT1 and GLUT2 in intestinal glucose transport and sensing. PLoS One. 2014 Feb 26;9(2):e89977. | |||||
11 | The sodium/glucose cotransport family SLC5. Pflugers Arch. 2004 Feb;447(5):510-8. | |||||
12 | SLC5A9/SGLT4, a new Na+-dependent glucose transporter, is an essential transporter for mannose, 1,5-anhydro-D-glucitol, and fructose. Life Sci. 2005 Jan 14;76(9):1039-50. | |||||
13 | Dysfunction of the Cerebral Glucose Transporter SLC45A1 in Individuals with Intellectual Disability and Epilepsy. Am J Hum Genet. 2017 May 4;100(5):824-830. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.